The Prince of Wales visited a cancer research centre to learn how Covid-19 has affected its funding today - and was gifted tie-dye bags for Camilla and Kate Middleton by a schoolboy who raised £1,850 for the charity.
Prince Charles, 72, who is patron of Breast Cancer Now, arrived at the organisation s Toby Robins Research Centre, at The Institute of Cancer Research, in London s Fulham Road, 21 years after he opened it.
He was greeted by the charity s chief executive, Baroness Delyth Morgan, before going to a research lab.
The prince heard from Dr Rachel Brough, senior scientific officer at the Institute of Cancer Research, and Dr Alicia Okines, consultant medical oncologist at the Royal Marsden NHS Foundation Trust, about an innovative trial at the research centre.
DS: Very special, particularly for you as a royal-phile.
MP: I can t believe it. I still can t believe it and we did it
DS: Refuse to believe it.
MP: Yeah.
DS: Prince Harry, the Duke of Sussex. Of course, he s a member of the British Royal Family, the younger son of Charles, Prince of Wales and Diana, Princess of Wales. Radical dude.
MP: So cool.
DS: Had zero idea what kind of guy he was.
MP: Yeah, I thought he was gonna be a little more stiff, like a little bit, royal.
DS: Yes.
MP: And he was very fun.
Three-drug combination moves forward for advanced breast cancer 11
Image: Breast cancer cells. Credit: Ewa Krawczyk
A combination of three drugs is safe and shows signs of effectiveness in treating some patients with previously treated advanced breast cancer, a clinical trial shows.
The ‘triplet therapy’ combines the hormone therapy fulvestrant with two targeted drugs, called palbociclib and taselisib, that block cells from multiplying and dividing.
A total of 78 patients with breast or other cancers were enrolled in the trial, and were given either the triplet therapy or a ‘doublet’ therapy of the targeted drugs without fulvestrant.
The triplet therapy showed particular promise in the 25 patients with advanced and previously treated oestrogen receptor positive, HER-2 negative breast cancer with mutations in the
Existing drug offers targeted treatment for aggressive breast cancer pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.